_id
691483cdccc777a4e85d9494
Ticker
NRIX
Name
Nurix Therapeutics Inc
Exchange
NASDAQ
Address
1700 Owens Street, San Francisco, CA, United States, 94158
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.nurixtx.com
Description
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 1B/2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader, that is in Phase 1A clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1A clinical trials to treat immuno-oncology indications. It is also developing NX 0479/GS 6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.
Last Close
19.01
Volume
1914151
Current Price
18.47
Change
-2.840610205155196
Last Updated
2025-12-02T12:42:17.737Z
Image
data:image/webp;base64,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
Ipo Date
2020-07-24T00:00:00.000Z
Market Cap
1714153728
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.96575
Sentiment Sources
4
Rating
4.4444
Target Price
27.1765
Strong Buy
10
Buy
6
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-08-31
Revenue
7894000
Cost Of Revenue
5000000
Gross Profit
2894000
Operating Expenses
94279000
Operating Income
-91385000
Interest Expense
-
Pretax Income
-86421000
Net Income
-86421000
Eps
-1.0268735960559385
Dividends Per Share
-
Shares Outstanding
101369235
Income Tax Expense
-
EBITDA
-81421000
Operating Margin
-1157.651380795541
Total Other Income Expense Net
4964000
Cash
78438000
Short Term Investments
350391000
Receivables
1700000
Inventories
-
Total Current Assets
440603000
Property Plant Equipment
73526000
Total Assets
522472000
Payables
8609000
Short Term Debt
3791000
Long Term Debt
-
Total Liabilities
150220000
Equity
372252000
Depreciation
5000000
Change In Working Capital
16460999
Cash From Operations
-57385000
Capital Expenditures
2711000
Cash From Investing
50475000
Cash From Financing
1155000
Net Change In Cash
-5755000
PE
-
PB
4.175727560684698
ROE
-23.215724831565712
ROA
-16.540790702659663
FCF
-60096000
Fcf Percent
-7.6128705345832275
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
7894000
Quarters > 0 > income Statement > cost Of Revenue
5000000
Quarters > 0 > income Statement > gross Profit
2894000
Quarters > 0 > income Statement > operating Expenses
94279000
Quarters > 0 > income Statement > operating Income
-91385000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-86421000
Quarters > 0 > income Statement > net Income
-86421000
Quarters > 0 > income Statement > eps
-1.0268735960559385
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
84159336
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-81421000
Quarters > 0 > income Statement > operating Margin
-1157.651380795541
Quarters > 0 > income Statement > total Other Income Expense Net
4964000
Quarters > 0 > balance Sheet > cash
78438000
Quarters > 0 > balance Sheet > short Term Investments
350391000
Quarters > 0 > balance Sheet > receivables
1700000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
440603000
Quarters > 0 > balance Sheet > property Plant Equipment
73526000
Quarters > 0 > balance Sheet > total Assets
522472000
Quarters > 0 > balance Sheet > payables
8609000
Quarters > 0 > balance Sheet > short Term Debt
3791000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
150220000
Quarters > 0 > balance Sheet > equity
372252000
Quarters > 0 > cash Flow > net Income
-86421000
Quarters > 0 > cash Flow > depreciation
5000000
Quarters > 0 > cash Flow > change In Working Capital
16460999
Quarters > 0 > cash Flow > cash From Operations
-57385000
Quarters > 0 > cash Flow > capital Expenditures
2711000
Quarters > 0 > cash Flow > cash From Investing
50475000
Quarters > 0 > cash Flow > cash From Financing
1155000
Quarters > 0 > cash Flow > net Change In Cash
-5755000
Quarters > 0 > ratios > PE
-1.0268735960559385
Quarters > 0 > ratios > PB
4.175727560684698
Quarters > 0 > ratios > ROE
-23.215724831565712
Quarters > 0 > ratios > ROA
-16.540790702659663
Quarters > 0 > ratios > FCF
-60096000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-7.6128705345832275
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-05-31
Quarters > 1 > income Statement > revenue
44056000
Quarters > 1 > income Statement > cost Of Revenue
78096000
Quarters > 1 > income Statement > gross Profit
-34040000
Quarters > 1 > income Statement > operating Expenses
14282000
Quarters > 1 > income Statement > operating Income
-48322000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-42704000
Quarters > 1 > income Statement > net Income
-43464000
Quarters > 1 > income Statement > eps
-0.518153511370438
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
83882477
Quarters > 1 > income Statement > income Tax Expense
760000
Quarters > 1 > income Statement > EBITDA
-46080000
Quarters > 1 > income Statement > operating Margin
-109.68313056110406
Quarters > 1 > income Statement > total Other Income Expense Net
5618000
Quarters > 1 > balance Sheet > cash
84260000
Quarters > 1 > balance Sheet > short Term Investments
401521000
Quarters > 1 > balance Sheet > receivables
19000000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
515330000
Quarters > 1 > balance Sheet > property Plant Equipment
68987000
Quarters > 1 > balance Sheet > total Assets
591555000
Quarters > 1 > balance Sheet > payables
5954000
Quarters > 1 > balance Sheet > short Term Debt
5235000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
143952000
Quarters > 1 > balance Sheet > equity
447603000
Quarters > 1 > cash Flow > net Income
-43464000
Quarters > 1 > cash Flow > depreciation
5097000
Quarters > 1 > cash Flow > change In Working Capital
-32478000
Quarters > 1 > cash Flow > cash From Operations
-63161000
Quarters > 1 > cash Flow > capital Expenditures
2675000
Quarters > 1 > cash Flow > cash From Investing
71499000
Quarters > 1 > cash Flow > cash From Financing
6000
Quarters > 1 > cash Flow > net Change In Cash
8344000
Quarters > 1 > ratios > PE
-0.518153511370438
Quarters > 1 > ratios > PB
3.461347109358069
Quarters > 1 > ratios > ROE
-9.710390681027608
Quarters > 1 > ratios > ROA
-7.3474148642138095
Quarters > 1 > ratios > FCF
-65836000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.494370800798983
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2025-02-28
Quarters > 2 > income Statement > revenue
18453000
Quarters > 2 > income Statement > cost Of Revenue
69663000
Quarters > 2 > income Statement > gross Profit
-51210000
Quarters > 2 > income Statement > operating Expenses
11654000
Quarters > 2 > income Statement > operating Income
-62864000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-56351000
Quarters > 2 > income Statement > net Income
-56351000
Quarters > 2 > income Statement > eps
-0.6743712766255994
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
83560795
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-60514000
Quarters > 2 > income Statement > operating Margin
-340.67089362163335
Quarters > 2 > income Statement > total Other Income Expense Net
6513000
Quarters > 2 > balance Sheet > cash
75916000
Quarters > 2 > balance Sheet > short Term Investments
473764000
Quarters > 2 > balance Sheet > receivables
9100000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
563703000
Quarters > 2 > balance Sheet > property Plant Equipment
44810000
Quarters > 2 > balance Sheet > total Assets
615043000
Quarters > 2 > balance Sheet > payables
8397000
Quarters > 2 > balance Sheet > short Term Debt
6639000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
134126000
Quarters > 2 > balance Sheet > equity
480917000
Quarters > 2 > cash Flow > net Income
-56351000
Quarters > 2 > cash Flow > depreciation
4128000
Quarters > 2 > cash Flow > change In Working Capital
-14029000
Quarters > 2 > cash Flow > cash From Operations
-61087000
Quarters > 2 > cash Flow > capital Expenditures
3485000
Quarters > 2 > cash Flow > cash From Investing
25533000
Quarters > 2 > cash Flow > cash From Financing
1473000
Quarters > 2 > cash Flow > net Change In Cash
-34081000
Quarters > 2 > ratios > PE
-0.6743712766255994
Quarters > 2 > ratios > PB
3.2092188124977903
Quarters > 2 > ratios > ROE
-11.717406537926504
Quarters > 2 > ratios > ROA
-9.162123623876704
Quarters > 2 > ratios > FCF
-64572000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-3.499268411640384
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-11-30
Quarters > 3 > income Statement > revenue
13284000
Quarters > 3 > income Statement > cost Of Revenue
67224000
Quarters > 3 > income Statement > gross Profit
-53940000
Quarters > 3 > income Statement > operating Expenses
10717000
Quarters > 3 > income Statement > operating Income
-64657000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-58541000
Quarters > 3 > income Statement > net Income
-58549000
Quarters > 3 > income Statement > eps
-0.7466969890762932
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
78410655
Quarters > 3 > income Statement > income Tax Expense
8000
Quarters > 3 > income Statement > EBITDA
-63408000
Quarters > 3 > income Statement > operating Margin
-486.7283950617284
Quarters > 3 > income Statement > total Other Income Expense Net
6116000
Quarters > 3 > balance Sheet > cash
109997000
Quarters > 3 > balance Sheet > short Term Investments
499586000
Quarters > 3 > balance Sheet > receivables
1500000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
619387000
Quarters > 3 > balance Sheet > property Plant Equipment
45896000
Quarters > 3 > balance Sheet > total Assets
669343000
Quarters > 3 > balance Sheet > payables
11482000
Quarters > 3 > balance Sheet > short Term Debt
8014000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
142350000
Quarters > 3 > balance Sheet > equity
526993000
Quarters > 3 > cash Flow > net Income
-58549000
Quarters > 3 > cash Flow > depreciation
4303000
Quarters > 3 > cash Flow > change In Working Capital
449000
Quarters > 3 > cash Flow > cash From Operations
-48751000
Quarters > 3 > cash Flow > capital Expenditures
2105000
Quarters > 3 > cash Flow > cash From Investing
-140817000
Quarters > 3 > cash Flow > cash From Financing
200521000
Quarters > 3 > cash Flow > net Change In Cash
10953000
Quarters > 3 > ratios > PE
-0.7466969890762932
Quarters > 3 > ratios > PB
2.7481290982043403
Quarters > 3 > ratios > ROE
-11.110014744028858
Quarters > 3 > ratios > ROA
-8.747234228190926
Quarters > 3 > ratios > FCF
-50856000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.82836495031617
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-11-30
Annuals > 0 > income Statement > revenue
54549000
Annuals > 0 > income Statement > cost Of Revenue
221632000
Annuals > 0 > income Statement > gross Profit
-167083000
Annuals > 0 > income Statement > operating Expenses
45944000
Annuals > 0 > income Statement > operating Income
-213027000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-193299000
Annuals > 0 > income Statement > net Income
-193569000
Annuals > 0 > income Statement > eps
-2.8839128855657394
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
67120266
Annuals > 0 > income Statement > income Tax Expense
270000
Annuals > 0 > income Statement > EBITDA
-205009000
Annuals > 0 > income Statement > operating Margin
-390.5241159324644
Annuals > 0 > income Statement > total Other Income Expense Net
19728000
Annuals > 0 > balance Sheet > cash
109997000
Annuals > 0 > balance Sheet > short Term Investments
499586000
Annuals > 0 > balance Sheet > receivables
1500000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
619387000
Annuals > 0 > balance Sheet > property Plant Equipment
45896000
Annuals > 0 > balance Sheet > total Assets
669343000
Annuals > 0 > balance Sheet > payables
11482000
Annuals > 0 > balance Sheet > short Term Debt
8014000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
142350000
Annuals > 0 > balance Sheet > equity
526993000
Annuals > 0 > cash Flow > net Income
-193569000
Annuals > 0 > cash Flow > depreciation
16428000
Annuals > 0 > cash Flow > change In Working Capital
-18401000
Annuals > 0 > cash Flow > cash From Operations
-172584000
Annuals > 0 > cash Flow > capital Expenditures
9273000
Annuals > 0 > cash Flow > cash From Investing
-257713000
Annuals > 0 > cash Flow > cash From Financing
485667000
Annuals > 0 > cash Flow > net Change In Cash
55370000
Annuals > 0 > ratios > PE
-2.8839128855657394
Annuals > 0 > ratios > PB
2.153735814441558
Annuals > 0 > ratios > ROE
-36.730848417341406
Annuals > 0 > ratios > ROA
-28.919253656197196
Annuals > 0 > ratios > FCF
-181857000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.3338283011604246
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-11-30
Annuals > 1 > income Statement > revenue
76987000
Annuals > 1 > income Statement > cost Of Revenue
189148000
Annuals > 1 > income Statement > gross Profit
-112161000
Annuals > 1 > income Statement > operating Expenses
42902000
Annuals > 1 > income Statement > operating Income
-155063000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-143948000
Annuals > 1 > income Statement > net Income
-143948000
Annuals > 1 > income Statement > eps
-2.649126987809117
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
54337901
Annuals > 1 > income Statement > income Tax Expense
13486105
Annuals > 1 > income Statement > EBITDA
-148930000
Annuals > 1 > income Statement > operating Margin
-201.41452453011544
Annuals > 1 > income Statement > total Other Income Expense Net
11115000
Annuals > 1 > balance Sheet > cash
54627000
Annuals > 1 > balance Sheet > short Term Investments
233281000
Annuals > 1 > balance Sheet > receivables
800000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
295503000
Annuals > 1 > balance Sheet > property Plant Equipment
47950000
Annuals > 1 > balance Sheet > total Assets
355598000
Annuals > 1 > balance Sheet > payables
6401000
Annuals > 1 > balance Sheet > short Term Debt
7489000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
155105000
Annuals > 1 > balance Sheet > equity
200493000
Annuals > 1 > cash Flow > net Income
-143948000
Annuals > 1 > cash Flow > depreciation
13654000
Annuals > 1 > cash Flow > change In Working Capital
20121000
Annuals > 1 > cash Flow > cash From Operations
-81365000
Annuals > 1 > cash Flow > capital Expenditures
8401000
Annuals > 1 > cash Flow > cash From Investing
68301000
Annuals > 1 > cash Flow > cash From Financing
3217000
Annuals > 1 > cash Flow > net Change In Cash
-9847000
Annuals > 1 > ratios > PE
-2.649126987809117
Annuals > 1 > ratios > PB
4.582972502331752
Annuals > 1 > ratios > ROE
-71.79702034484995
Annuals > 1 > ratios > ROA
-40.480542635222925
Annuals > 1 > ratios > FCF
-89766000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.1659890630885734
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-11-30
Annuals > 2 > income Statement > revenue
38627000
Annuals > 2 > income Statement > cost Of Revenue
10808000
Annuals > 2 > income Statement > gross Profit
38627000
Annuals > 2 > income Statement > operating Expenses
222494000
Annuals > 2 > income Statement > operating Income
-183867000
Annuals > 2 > income Statement > interest Expense
14315000
Annuals > 2 > income Statement > pretax Income
-180360000
Annuals > 2 > income Statement > net Income
-166045000
Annuals > 2 > income Statement > eps
-3.4160021840030828
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
48607990
Annuals > 2 > income Statement > income Tax Expense
-14315000
Annuals > 2 > income Statement > EBITDA
-173059000
Annuals > 2 > income Statement > operating Margin
-476.0064203795273
Annuals > 2 > income Statement > total Other Income Expense Net
3507000
Annuals > 2 > balance Sheet > cash
64474000
Annuals > 2 > balance Sheet > short Term Investments
244667000
Annuals > 2 > balance Sheet > receivables
1100000
Annuals > 2 > balance Sheet > inventories
-1100000
Annuals > 2 > balance Sheet > total Current Assets
318449000
Annuals > 2 > balance Sheet > property Plant Equipment
29508000
Annuals > 2 > balance Sheet > total Assets
416759000
Annuals > 2 > balance Sheet > payables
5064000
Annuals > 2 > balance Sheet > short Term Debt
5530000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
113063000
Annuals > 2 > balance Sheet > equity
303696000
Annuals > 2 > cash Flow > net Income
-180360000
Annuals > 2 > cash Flow > depreciation
10808000
Annuals > 2 > cash Flow > change In Working Capital
-19022000
Annuals > 2 > cash Flow > cash From Operations
-159807000
Annuals > 2 > cash Flow > capital Expenditures
12244000
Annuals > 2 > cash Flow > cash From Investing
27198000
Annuals > 2 > cash Flow > cash From Financing
117192000
Annuals > 2 > cash Flow > net Change In Cash
-15417000
Annuals > 2 > ratios > PE
-3.4160021840030828
Annuals > 2 > ratios > PB
2.7065259697197197
Annuals > 2 > ratios > ROE
-54.67474053000368
Annuals > 2 > ratios > ROA
-39.841971019222136
Annuals > 2 > ratios > FCF
-172051000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.454164185673234
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-11-30
Annuals > 3 > income Statement > revenue
29750000
Annuals > 3 > income Statement > cost Of Revenue
6082000
Annuals > 3 > income Statement > gross Profit
29750000
Annuals > 3 > income Statement > operating Expenses
147636000
Annuals > 3 > income Statement > operating Income
-117886000
Annuals > 3 > income Statement > interest Expense
6905000
Annuals > 3 > income Statement > pretax Income
-117063000
Annuals > 3 > income Statement > net Income
-117194000
Annuals > 3 > income Statement > eps
-2.7320889056987787
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
42895383
Annuals > 3 > income Statement > income Tax Expense
131000
Annuals > 3 > income Statement > EBITDA
-111804000
Annuals > 3 > income Statement > operating Margin
-396.255462184874
Annuals > 3 > income Statement > total Other Income Expense Net
823000
Annuals > 3 > balance Sheet > cash
80506000
Annuals > 3 > balance Sheet > short Term Investments
215214000
Annuals > 3 > balance Sheet > receivables
6204000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
311118000
Annuals > 3 > balance Sheet > property Plant Equipment
25345000
Annuals > 3 > balance Sheet > total Assets
476771000
Annuals > 3 > balance Sheet > payables
6650000
Annuals > 3 > balance Sheet > short Term Debt
3847000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
134469000
Annuals > 3 > balance Sheet > equity
342302000
Annuals > 3 > cash Flow > net Income
-117194000
Annuals > 3 > cash Flow > depreciation
6082000
Annuals > 3 > cash Flow > change In Working Capital
9113000
Annuals > 3 > cash Flow > cash From Operations
-84365000
Annuals > 3 > cash Flow > capital Expenditures
5661000
Annuals > 3 > cash Flow > cash From Investing
-108251000
Annuals > 3 > cash Flow > cash From Financing
153882000
Annuals > 3 > cash Flow > net Change In Cash
-38734000
Annuals > 3 > ratios > PE
-2.7320889056987787
Annuals > 3 > ratios > PB
2.1190671586201657
Annuals > 3 > ratios > ROE
-34.23701877289645
Annuals > 3 > ratios > ROA
-24.580773578929925
Annuals > 3 > ratios > FCF
-90026000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-3.0260840336134454
Annuals > 3 > health Score
35
Valuation > metrics > PE
-1.0268735960559385
Valuation > metrics > PB
4.175727560684698
Valuation > final Score
38.24272439315302
Valuation > verdict
39.2% Overvalued
Profitability > metrics > ROE
-23.215724831565712
Profitability > metrics > ROA
-19.61425591745857
Profitability > metrics > Net Margin
-10.94768178363314
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.40354383589611337
Risk > metrics > Interest Coverage
-18.277
Risk > final Score
-13
Risk > verdict
High
Liquidity > metrics > Current Ratio
35.5325
Liquidity > metrics > Quick Ratio
35.5325
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
45.38652890641931
Prev Valuations > 1
47.9078118750221
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
3
Prev Risks > 1
0
Prev Risks > 2
7
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T23:05:26.708Z
Earnings History > 0 > period
2025-11-30
Earnings History > 0 > report Date
2026-02-18
Earnings History > 0 > date
2025-11-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.8777
Earnings History > 0 > eps Difference
0.8777
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-08-31
Earnings History > 1 > report Date
2025-10-09
Earnings History > 1 > date
2025-08-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.03
Earnings History > 1 > eps Estimate
-0.8296
Earnings History > 1 > eps Difference
-0.2004
Earnings History > 1 > surprise Percent
-24.1562
Earnings History > 2 > period
2025-05-31
Earnings History > 2 > report Date
2025-07-09
Earnings History > 2 > date
2025-05-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.52
Earnings History > 2 > eps Estimate
-0.714
Earnings History > 2 > eps Difference
0.194
Earnings History > 2 > surprise Percent
27.1709
Earnings History > 3 > period
2025-02-28
Earnings History > 3 > report Date
2025-04-08
Earnings History > 3 > date
2025-02-28
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.67
Earnings History > 3 > eps Estimate
-0.7614
Earnings History > 3 > eps Difference
0.0914
Earnings History > 3 > surprise Percent
12.0042
Earnings History > 4 > period
2024-11-30
Earnings History > 4 > report Date
2025-02-13
Earnings History > 4 > date
2024-11-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.75
Earnings History > 4 > eps Estimate
-0.6689
Earnings History > 4 > eps Difference
-0.0811
Earnings History > 4 > surprise Percent
-12.1244
Earnings History > 5 > period
2024-08-31
Earnings History > 5 > report Date
2024-10-11
Earnings History > 5 > date
2024-08-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.67
Earnings History > 5 > eps Estimate
-0.71
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
5.6338
Earnings History > 6 > period
2024-05-31
Earnings History > 6 > report Date
2024-07-11
Earnings History > 6 > date
2024-05-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.71
Earnings History > 6 > eps Estimate
-0.63
Earnings History > 6 > eps Difference
-0.08
Earnings History > 6 > surprise Percent
-12.6984
Earnings History > 7 > period
2024-02-29
Earnings History > 7 > report Date
2024-04-10
Earnings History > 7 > date
2024-02-29
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.76
Earnings History > 7 > eps Estimate
-0.8
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
5
Earnings History > 8 > period
2023-11-30
Earnings History > 8 > report Date
2024-02-15
Earnings History > 8 > date
2023-11-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.77
Earnings History > 8 > eps Estimate
-0.57
Earnings History > 8 > eps Difference
-0.2
Earnings History > 8 > surprise Percent
-35.0877
Earnings History > 9 > period
2023-08-31
Earnings History > 9 > report Date
2023-10-12
Earnings History > 9 > date
2023-08-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.68
Earnings History > 9 > eps Estimate
-0.76
Earnings History > 9 > eps Difference
0.08
Earnings History > 9 > surprise Percent
10.5263
Earnings History > 10 > period
2023-05-31
Earnings History > 10 > report Date
2023-07-13
Earnings History > 10 > date
2023-05-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.45
Earnings History > 10 > eps Estimate
-0.56
Earnings History > 10 > eps Difference
0.11
Earnings History > 10 > surprise Percent
19.6429
Earnings History > 11 > period
2023-02-28
Earnings History > 11 > report Date
2023-04-13
Earnings History > 11 > date
2023-02-28
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.75
Earnings History > 11 > eps Estimate
-0.87
Earnings History > 11 > eps Difference
0.12
Earnings History > 11 > surprise Percent
13.7931
Earnings History > 12 > period
2022-11-30
Earnings History > 12 > report Date
2023-02-09
Earnings History > 12 > date
2022-11-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.87
Earnings History > 12 > eps Estimate
-0.79
Earnings History > 12 > eps Difference
-0.08
Earnings History > 12 > surprise Percent
-10.1266
Earnings History > 13 > period
2022-08-31
Earnings History > 13 > report Date
2022-10-06
Earnings History > 13 > date
2022-08-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.9
Earnings History > 13 > eps Estimate
-0.98
Earnings History > 13 > eps Difference
0.08
Earnings History > 13 > surprise Percent
8.1633
Earnings History > 14 > period
2022-05-31
Earnings History > 14 > report Date
2022-07-07
Earnings History > 14 > date
2022-05-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.01
Earnings History > 14 > eps Estimate
-0.99
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-2.0202
Earnings History > 15 > period
2022-02-28
Earnings History > 15 > report Date
2022-04-07
Earnings History > 15 > date
2022-02-28
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.95
Earnings History > 15 > eps Estimate
-0.88
Earnings History > 15 > eps Difference
-0.07
Earnings History > 15 > surprise Percent
-7.9545
Earnings History > 16 > period
2021-11-30
Earnings History > 16 > report Date
2022-01-27
Earnings History > 16 > date
2021-11-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.85
Earnings History > 16 > eps Estimate
-0.69
Earnings History > 16 > eps Difference
-0.16
Earnings History > 16 > surprise Percent
-23.1884
Earnings History > 17 > period
2021-08-31
Earnings History > 17 > report Date
2021-10-14
Earnings History > 17 > date
2021-08-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.65
Earnings History > 17 > eps Estimate
-0.63
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-3.1746
Earnings History > 18 > period
2021-05-31
Earnings History > 18 > report Date
2021-07-13
Earnings History > 18 > date
2021-05-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.6
Earnings History > 18 > eps Estimate
-0.54
Earnings History > 18 > eps Difference
-0.06
Earnings History > 18 > surprise Percent
-11.1111
Earnings History > 19 > period
2021-02-28
Earnings History > 19 > report Date
2021-04-13
Earnings History > 19 > date
2021-02-28
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.63
Earnings History > 19 > eps Estimate
-0.46
Earnings History > 19 > eps Difference
-0.17
Earnings History > 19 > surprise Percent
-36.9565
Earnings History > 20 > period
2020-11-30
Earnings History > 20 > report Date
2021-02-16
Earnings History > 20 > date
2020-11-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.51
Earnings History > 20 > eps Estimate
-0.54
Earnings History > 20 > eps Difference
0.03
Earnings History > 20 > surprise Percent
5.5556
Earnings History > 21 > period
2020-08-31
Earnings History > 21 > report Date
2020-10-14
Earnings History > 21 > date
2020-08-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.59
Earnings History > 21 > eps Estimate
-0.41
Earnings History > 21 > eps Difference
-0.18
Earnings History > 21 > surprise Percent
-43.9024
Earnings History > 22 > period
2020-05-31
Earnings History > 22 > report Date
2020-07-24
Earnings History > 22 > date
2020-05-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.09
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-02-29
Earnings History > 23 > report Date
2020-05-05
Earnings History > 23 > date
2020-02-29
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.91
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-1.91
Earnings History > 23 > surprise Percent
-
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 1B/2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader, that is in Phase 1A clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1A clinical trials to treat immuno-oncology indications. It is also developing NX 0479/GS 6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWells Fargo Raises Price Target for Nurix Therapeutics (NRIX) to $30 | NRIX Stock News - GuruFocus
12/16/2025
Wells Fargo Raises Price Target for Nurix Therapeutics (NRIX) to $30 | NRIX Stock News GuruFocus
Read more →Nurix Therapeutics (NASDAQ:NRIX) Given New $30.00 Price Target at Wells Fargo & Company - MarketBeat
12/16/2025
Nurix Therapeutics (NASDAQ:NRIX) Given New $30.00 Price Target at Wells Fargo & Company MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-08-31)
Rating:
BUY
Target Price:
$27.1765
Analyst Picks
Strong Buy
10
Buy
6
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bearish
(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 118.27% of the total shares of Nurix Therapeutics Inc
1.
FMR Inc(13.6593%)
since
2025/06/30
2.
BlackRock Inc(8.9062%)
since
2025/06/30
3.
Deep Track Capital, LP(7.9332%)
since
2025/06/30
4.
Vanguard Group Inc(5.8411%)
since
2025/06/30
5.
COMMODORE CAPITAL LP(5.1651%)
since
2025/06/30
6.
Baker Bros Advisors LP(5.078%)
since
2025/06/30
7.
Redmile Group, LLC(4.8828%)
since
2025/06/30
8.
Point72 Asset Management, L.P.(4.8445%)
since
2025/06/30
9.
T. Rowe Price Associates, Inc.(3.9684%)
since
2025/06/30
10.
State Street Corp(3.3122%)
since
2025/06/30
11.
T. Rowe Price Investment Management,Inc.(3.2361%)
since
2025/06/30
12.
Soleus Capital Management, L.P.(3.1692%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(3.1599%)
since
2025/07/31
14.
Morgan Stanley - Brokerage Accounts(2.8347%)
since
2025/06/30
15.
Vestal Point Capital LP(2.6161%)
since
2025/06/30
16.
Pictet Asset Manangement SA(2.6143%)
since
2025/06/30
17.
Geode Capital Management, LLC(2.4617%)
since
2025/06/30
18.
iShares Russell 2000 ETF(2.3772%)
since
2025/08/31
19.
Fidelity Select Health Care(2.2106%)
since
2025/07/31
20.
UBS Group AG(2.0786%)
since
2025/06/30
21.
Citadel Advisors Llc(2.0785%)
since
2025/06/30
22.
ARK Investment Management LLC(2.0602%)
since
2025/06/30
23.
ARK Genomic Revolution(2.0081%)
since
2025/06/30
24.
ARK Genomic Revolution ETF(2.0057%)
since
2025/08/28
25.
Wellington Management Company LLP(1.9164%)
since
2025/06/30
26.
Amova ARK Pstv Chg Innovt P JPY Acc(1.859%)
since
2025/07/31
27.
US Small-Cap Growth II Equity Comp(1.7633%)
since
2025/06/30
28.
Strategic Advisers Fidelity US TtlStk(1.3527%)
since
2025/07/31
29.
Fidelity Advisor Health Care I(1.3081%)
since
2025/07/31
30.
T. Rowe Price New Horizons(1.3076%)
since
2025/07/31
31.
Pictet-Biotech P USD(1.2843%)
since
2025/05/31
32.
Fidelity Small Cap Growth(1.2441%)
since
2025/06/30
33.
SPDR® S&P Biotech ETF(1.2067%)
since
2025/08/31
34.
Fidelity Growth Compy Commingled Pl S(1.0542%)
since
2025/07/31
35.
Vanguard Institutional Extnd Mkt Idx Tr(0.9943%)
since
2025/07/31
36.
Fidelity Small Cap Index(0.9901%)
since
2025/06/30
37.
Pictet-Global Megatrend Sel I USD(0.918%)
since
2025/05/31
38.
iShares Russell 2000 Value ETF(0.8667%)
since
2025/08/31
39.
Fidelity Advisor Biotechnology I(0.857%)
since
2025/07/31
40.
Fidelity Growth Company Fund(0.8499%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-11-30
EPS Estimate
-0.8777
Date
2025-08-31
EPS Actual
-1.03
EPS Estimate
-0.8296
EPS Difference
-0.2004
Surprise Percent
-24.1562%
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.